Clinical Trial Update: Clonal Hematopoiesis of Immunological Significance

View source ↗

Summary

This is a clinical trial update about clonal hematopoiesis of immunological significance (CHIS) sponsored by Assistance Publique - Hôpitaux de Paris; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Clonal Hematopoiesis of Indeterminate Potential
• Leukemia
• Lymphoma
• Monoclonal Gammopathy of Undetermined Significance
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms
• Vexas Syndrome

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Immune System Diseases, Autoimmune Diseases | Status: NOT_YET_RECRUITING